The growing need for continuous and subcutaneous drug delivery has developed the demand for wearable injectors among the patients. With the explosive growth of bolus injectors and increasing interest of pharmaceutical companies in collaborating with device manufacturers for drug device combination, the market for wearable injectors is expected to show dramatic rise. The launch of bolus injector expands the usage of wearable injectors from diabetes to other disease segments, as the wearable injectors currently available in market are majorly insulin pumps.
2. According to a new market research report “Global Wearable Injectors Market Size,
Share, Development, Growth and Demand Forecast to 2024 – Industry Insights by
Type (Body-Worn Patch Injector, Off-Body Worn Belt Injector and Others), by
Technology (Electronic Injector, Mechanical Injector and Others), by Application
(Cancer, Infectious Disease, Autoimmune Disorder, Cardiovascular Disease, Blood
Disorder and Others), by End User (Home Care, Hospital, Lab & Diagnostics and
Others), published by P&S Market Research, the global wearable injectors market is
projected to reach $13,015.9 million by 2024, growing at a CAGR of 23.0% during
2016 - 2024.
Access Report Overview: https://www.psmarketresearch.com/market-
analysis/wearable-injectors-market
Wearable Injectors Market
3. Wearable Injectors Market
As per the research, the global wearable injectors market is likely to grow
from $2,162.1 million in 2015 to $13.0 billion by 2024. With the explosive
growth of bolus injectors and increasing interest of pharmaceutical
companies in collaborating with device manufacturers for drug device
combination, the market for wearable injectors is expected to show
dramatic rise. The launch of bolus injector expands the usage of wearable
injectors from diabetes to other disease segments, as the wearable
injectors currently available in market are majorly insulin pumps. The
growing need for continuous and subcutaneous drug delivery has
developed the demand for wearable injectors among the patients.
Global wearable injectors market worth $2,162.1
million in 2015
4. Wearable Injectors Market
As per the findings of the research, cancer is expected to be the largest
application area of wearable injectors. According to the analyst, cancer and
autoimmune disease are expected to be the major application areas for
wearable injectors in the near future. The other key applications of
wearable injectors include infectious disease, cardiovascular disease and
blood disorders. Also, homecare is expected to be the largest end user of
wearable injectors.
Insights on market segments
5. Wearable Injectors Market
Geographically, North America has been the largest market for wearable
injectors, where the U.S. has been the largest contributor to the regional
market during 2013 - 2015. The North American wearable injectors market
is growing significantly due to increasing demand for self-injection system
and rising prevalence of chronic and lifestyle-associated diseases. According
to the CDC, approximately 117 million people in the U.S., i.e. about half of
its adult population, experienced one or more chronic health conditions in
2012. Japan has been the major market in Asia-Pacific; whereas in Europe,
Germany has been the highest revenue generator in 2015.
North America emerges as largest wearable
injectors market
6. Wearable Injectors Market
Growing need for advanced drug delivery is one of the major factors driving the
growth of the global wearable injectors market. Increasing demand for
homecare and advanced drug delivery requiring minimal expertise and lesser
hospitalization of patients is expected to drive the demand for wearable
injectors, globally. Also, many biopharmaceutical companies have been looking
for a better mode of drug delivery for their portfolio of biologic drugs, for which
wearable injectors are an appropriate solution.
Increasing need for better patient care is creating ample growth opportunities
for the global market. Electronic wearable injectors create yet another
opportunity for the global market, as these types of wearable injectors are
technically more advanced, do not require patient training and are easy to use.
As compared to these, mechanical wearable injectors are self-administration
devices that require one time administration of the drugs, manually, by the
patient. Mechanical wearable injectors are either pre-loaded or loaded at the
time of administration.
Growing need for advanced drug delivery to
bolster market growth
7. Wearable Injectors Market
The research states that the global wearable injectors market had a consolidated
structure in 2015, where the top three competitors accounted for the major share
in the global wearable injectors market. Some of the key players operating in the
global market are Becton, Dickinson and Company, Medtronic plc, Johnson &
Johnson, F. Hoffmann-La Roche Ltd., Insulet Corporation, Unilife Corporation,
CeQur SA, Enable Injections, ScPharmaceuticals, Inc., SteadyMed Ltd., Ypsomed
Group, West Pharmaceutical Services, Inc. and Canè S.p.A.
Different companies are collaborating to provide new solutions in the global
wearable injectors market. For instance, Ypsomed collaborated with Novo Nordisk
in June 2016, where the two companies were expected to provide new solutions
in insulin pump therapy. The company’s YpsoPump was compatible with
NovoRapid PumpCart by Novo Nordisk. NovoRapid is a prefilled pump cartridge
with an insulin analogue that has been especially designed for insulin pumps. The
collaboration aimed to simplify the use of insulin for the diabetes patients.
Top three players constitute the major market
share